SCHEMBL18235468

SCHEMBL18235468

COc1ccc(Oc2ccc(-c3n[nH]c4ncnc(N)c34)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.49
TEK Q02763 2/20 0.49
LCK P06239 1/20 0.49
SRC P12931 3/20 0.49
PIK3CD O00329 2/20 0.49
PIK3CA P42336 2/20 0.49
PIK3CB P42338 2/20 0.49
PIK3CG P48736 2/20 0.49
PRKDC P78527 2/20 0.49
ABL1 P00519 2/20 0.49
EGFR P00533 2/20 0.49
HCK P08631 1/20 0.49
MTOR P42345 1/20 0.49
EPHB4 P54760 1/20 0.49
PI4KB Q9UBF8 1/20 0.49
NUDT14 O95848 2/20 0.48
NUDT5 Q9UKK9 2/20 0.48
MAP4K4 O95819 2/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL149528 0.96 KDR (0.52) KDRTEKLCKSRCPIK3CD
SCHEMBL12713498 0.89 PIK3CD (0.50) KDRTEKLCKSRCPIK3CD
SCHEMBL200349 0.88 NUDT14 (0.62) KDRTEKLCKSRCPIK3CD
Hydrochloric Acid SCHEMBL29439185 0.86 NUDT14 (0.61) KDRTEKLCKSRCPIK3CD
SCHEMBL12808147 0.86 BTK (0.50) KDRTEKLCKSRCPIK3CD
SCHEMBL17626654 0.86 NUDT14 (0.48) LCKPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL19414290 0.84 SRC (0.57) KDRLCKSRCPIK3CDPIK3CA
SCHEMBL30416234 0.83 PIK3CA (0.45) KDRTEKLCKSRCPIK3CD
SCHEMBL22243273 0.82 PIK3CD (0.41) KDRTEKLCKSRCPIK3CD
SCHEMBL19414293 0.82 ALDH1A1 (0.50) KDRLCKSRCPIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116134028-A Compound capable of degrading BTK kinase, preparation method and pharmaceutical application thereof 四川海思科制药有限公司 2023-05-16 CN disclosed
WO-2016180334-A1 DUAL-SITE IRREVERSIBLE BRUTON'S TYROSINE KINASE INHIBITOR, COMPOSITION AND APPLICATION THEREFOF 杭州和正医药有限公司 2016-11-17 WO disclosed